We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00231257
Recruitment Status : Completed
First Posted : October 4, 2005
Last Update Posted : November 19, 2009
Information provided by:
Cordis Corporation